From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Genzyme Corp.

www.genzyme.com

Most Recent Related Deals

Sanofi launches $69 per share bid for Genzyme; $17.5bn value, 8/2010
test, 12/2009
Genzyme pays $3.5mm up front for Targeted Genetics' assets, 9/2009
Genzyme acquires rights to three drugs from Bayer HealthCare, 3/2009
Genzyme gets IP from Exact Sciences, 1/2009
Genzyme gets rights to Osiris's Prochymal and Chondrogen, 11/2008
Genzyme helps PTC develop and commercialize PTC124, 7/2008
Genzyme Genetics, DxS sign NSCLC agreement, 2/2008
Genzyme and Isis enter $1.2bn CV collaboration, 1/2008
Moffitt Cancer Center licenses Genzyme rights to NSCLC test, 1/2008

Most Recent Related Articles

Click an article to see a free preview (15 of 294).

Taking Lumps From Health Care Reform, Medtech Insight 6/2010
Best Of The IN VIVO Blog (06/2010), Start-Up 6/2010
For Shire, Life After Adderall XR? Yes, Start-Up 6/2010
Medtronic: Doing Just What the Doctors Order, Start-Up 6/2010
The Future of the Stem Cell Market, The Pink Sheet DAILY 5/2010
Health Care Reform: For Biopharmas There Is Much To Like, Start-Up 4/2010
Despite Challenges, Congestive Heart Failure Draws A Crowd, In Vivo 4/2010
OrbiMed Closes $550 Million Fund, In Vivo 3/2010
Early-Stage Biopharma Alliance Up-Fronts Rising; Late State Alliance Up-Fronts Falling? , In Vivo 3/2010
Helix Therapeutics LLC, In Vivo 3/2010
Big Pharma's Appetite for Biologics Platforms Fuels New Company Creation, In Vivo 2/2010
Despite Advances, Regenerative Medicine Faces Funding Crisis, In Vivo 2/2010
deCODE Re-Emerges: Can a Genomics Platform Model Work in Diagnostics? , In Vivo 2/2010
Orphaned No Longer: Big Pharma Embraces Drugs for Niche Markets, Start-Up 2/2010
Injectable Solutions for Joint and Back Pain, The Pink Sheet DAILY 1/2010

See all 294 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.